Free Trial
NASDAQ:PRPH

ProPhase Labs Q2 2025 Earnings Report

ProPhase Labs logo
$0.31 -0.01 (-4.26%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$0.33 +0.02 (+6.34%)
As of 08/8/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ProPhase Labs EPS Results

Actual EPS
N/A
Consensus EPS
-$0.15
Beat/Miss
N/A
One Year Ago EPS
N/A

ProPhase Labs Revenue Results

Actual Revenue
N/A
Expected Revenue
$3.55 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

ProPhase Labs Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Wednesday, August 13, 2025
Conference Call Time
11:00AM ET

Conference Call Resources

ProPhase Labs Earnings Headlines

ProPhase Labs Appoints New Fractional CFO
One stock to replace Nvidia
Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.
See More ProPhase Labs Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ProPhase Labs? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ProPhase Labs and other key companies, straight to your email.

About ProPhase Labs

ProPhase Labs (NASDAQ:PRPH) develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

View ProPhase Labs Profile

More Earnings Resources from MarketBeat